Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Organon & Co. Common Stock (NY:OGN)

9.920 -0.320 (-3.13%)
Official Closing Price Updated: 4:10 PM EDT, Oct 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,740,804
Open 10.30
Bid (Size) 9.930 (1)
Ask (Size) 9.990 (10)
Prev. Close 10.24
Today's Range 9.760 - 10.34
52wk Range 8.010 - 19.05
Shares Outstanding 253,545,051
Dividend Yield 0.81%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Q2 Earnings Highs And Lows: Organon (NYSE:OGN) Vs The Rest Of The Branded Pharmaceuticals Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Organon (NYSE:OGN) and the best and worst... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
3 Reasons to Avoid OGN and 1 Stock to Buy Instead
Over the past six months, Organon’s shares (currently trading at $11.05) have posted a disappointing 11.7% loss, well below the S&P 500’s 32.7% gain. This may have investors wondering how to approach... 
Via StockStory
Topics Government Stocks World Trade

Performance

YTD
-33.7%
-33.7%
1 Month
-5.3%
-5.3%
3 Month
+0.1%
+0.1%
6 Month
-21.5%
-21.5%
1 Year
-45.2%
-45.2%

More News

Read More
Healthcare Staffing Giant AMN Healthcare Soars Amidst Landmark Drug-Pricing Agreement
Via MarketMinute
Topics Government
Earnings Scheduled For August 5, 2025
Via Benzinga
A Look Ahead: Organon's Earnings Forecast
Via Benzinga
Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge
Via MarketMinute
Topics Economy Government World Trade
AbbVie, AMN Healthcare Services, LeMaitre, Waters Corporation, and Organon Shares Skyrocket, What You Need To Know
Via StockStory
Topics Government
1 Surging Stock Worth Your Attention and 2 We Avoid
Via StockStory
Topics Initial Public Offering
Johnson & Johnson's Hypothetical Rally: A Look at Potential 2025 Valuation Drivers
Via MarketMinute
Topics Economy Intellectual Property
Why Organon (OGN) Stock Is Trading Up Today
Via StockStory
Topics Artificial Intelligence Economy Initial Public Offering
3 Stocks Under $50 We Find Risky
Via StockStory
US Food and Drug Administration (FDA) Approves Henlius and Organon’s BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively
From Organon & Co.
Via Business Wire
3 Cash-Producing Stocks with Warning Signs
Via StockStory
1 Healthcare Stock Worth Investigating and 2 Facing Challenges
Via StockStory
Topics Stocks
Brookdale, Evolent Health, Fortrea, 10x Genomics, and Organon Stocks Trade Up, What You Need To Know
Via StockStory
Topics Artificial Intelligence Economy
OGN Q2 Deep Dive: Flat Sales, Margin Pressure, and Strategic Shifts Highlight Quarter
Via StockStory
3 of Wall Street’s Favorite Stocks We Find Risky
Via StockStory
Organon (OGN) Fiscal Q2 Revenue Beats 1%
Via The Motley Fool
Organon (NYSE:OGN) Surprises With Q2 Sales, Stock Soars
Via StockStory
Organon Reports Results for the Second Quarter Ended June 30, 2025
From Organon & Co.
Via Business Wire
Organon Earnings: What To Look For From OGN
Via StockStory
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon
From Faruqi & Faruqi, LLP
Via Business Wire
Organon & Co. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 22, 2025 to Discuss Your Rights - OGN
Via NewMediaWire
Topics Fraud Lawsuit
Organon & Co. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 22, 2025 to Discuss Your Rights - OGN
Via TheNewswire.com
Topics Fraud Lawsuit
ORGANON FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Organon & Co. (OGN) Investors of the July 22nd Deadline and Urges Them to Inquire About Their Rights in Class Action Lawsuit
From Bragar Eagel & Squire
Via GlobeNewswire

Frequently Asked Questions

Is Organon & Co. Common Stock publicly traded?
Yes, Organon & Co. Common Stock is publicly traded.
What exchange does Organon & Co. Common Stock trade on?
Organon & Co. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Organon & Co. Common Stock?
The ticker symbol for Organon & Co. Common Stock is OGN on the New York Stock Exchange
What is the current price of Organon & Co. Common Stock?
The current price of Organon & Co. Common Stock is 9.920
When was Organon & Co. Common Stock last traded?
The last trade of Organon & Co. Common Stock was at 10/09/25 04:10 PM ET
What is the market capitalization of Organon & Co. Common Stock?
The market capitalization of Organon & Co. Common Stock is 2.52B
How many shares of Organon & Co. Common Stock are outstanding?
Organon & Co. Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.